Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Нема приказа
Аутори
De Backer, G.Jankowski, P.
Dilić, M.
Lalić, N.
Lović, D.
Miličić, D.
Vulić, D.
Begić, A.
Durak Nalbantić, A.
Hadzibegić, N.
Kapidjić, S.
Resić, N.
Sabanović Bajramović, N.
Zvizdić, F.
Kovacević-Preradović, T.
Popović-Pejicić, S.
Đekić, D.
Gnjatić, T.
Knezević, T.
Stanetić, B.
Topić, G.
Milicić, D.
Bosnić, A.
Dubravcić, M.
Pavasović, S.
Samardžić, Jelena
Batinić, T.
Delić-Brkljacić, D.
Golubić, K.
Kordić, K.
Nedić, M.
Olujić, D.
Sedinić, V.
Blazević, T.
Pasalić, A.
Percić, M.
Sikić, J.
Aleksić, M.
Đokić, Jelena
Hinić, S.
Zdravković, M.
Lalić, N.M.
Jotić, A.
Lalić, K.
Lukić, L.
Milicić, T.
Macesić, M.
Stanarcić Gajović, J.
Stoiljković, M.
Đorđević, D.
Kostić, S.
Tasić, I.
Vuković, A.
Kugonjič, U.
(broj koatora 519)
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the ...advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.
Кључне речи:
Secondary prevention / Lipid lowering therapy / LDL-Cholesterol / EUROASPIRE / Dyslipidaemia / Coronary heart diseaseИзвор:
Atherosclerosis, 2019, 285, 135-146Издавач:
- Elsevier Ireland Ltd
Финансирање / пројекти:
- The EUROASPIRE V survey was carried out under the auspices of the ESC –EORP. Since the start of EORP, the following companies have supported the programme: Amgen, Eli Lilly, Pfizer, Sanofi, Ferrer and Novo Nordisk. The sponsors of the EUROASPIRE surveys had no role in the design, data collection, data analysis, data interpretation, decision to publish, or writing the manuscript. The EUROASPIRE Study Group is grateful to the administrative staff, physicians, nurses, and other personnel in the hospitals in which the survey was carried out and to all patients who participated in the surveys.
DOI: 10.1016/j.atherosclerosis.2019.03.014
ISSN: 0021-9150
PubMed: 31054483
WoS: 000468732700018
Scopus: 2-s2.0-85064931797
Институција/група
Institut za molekularnu genetiku i genetičko inženjerstvoTY - JOUR AU - De Backer, G. AU - Jankowski, P. AU - Dilić, M. AU - Lalić, N. AU - Lović, D. AU - Miličić, D. AU - Vulić, D. AU - Begić, A. AU - Durak Nalbantić, A. AU - Hadzibegić, N. AU - Kapidjić, S. AU - Resić, N. AU - Sabanović Bajramović, N. AU - Zvizdić, F. AU - Kovacević-Preradović, T. AU - Popović-Pejicić, S. AU - Đekić, D. AU - Gnjatić, T. AU - Knezević, T. AU - Stanetić, B. AU - Topić, G. AU - Milicić, D. AU - Bosnić, A. AU - Dubravcić, M. AU - Pavasović, S. AU - Samardžić, Jelena AU - Batinić, T. AU - Delić-Brkljacić, D. AU - Golubić, K. AU - Kordić, K. AU - Nedić, M. AU - Olujić, D. AU - Sedinić, V. AU - Blazević, T. AU - Pasalić, A. AU - Percić, M. AU - Sikić, J. AU - Aleksić, M. AU - Đokić, Jelena AU - Hinić, S. AU - Zdravković, M. AU - Lalić, N.M. AU - Jotić, A. AU - Lalić, K. AU - Lukić, L. AU - Milicić, T. AU - Macesić, M. AU - Stanarcić Gajović, J. AU - Stoiljković, M. AU - Đorđević, D. AU - Kostić, S. AU - Tasić, I. AU - Vuković, A. AU - Kugonjič, U. AU - (broj koatora 519) PY - 2019 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/1231 AB - Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient. PB - Elsevier Ireland Ltd T2 - Atherosclerosis T1 - Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries EP - 146 SP - 135 VL - 285 DO - 10.1016/j.atherosclerosis.2019.03.014 ER -
@article{ author = "De Backer, G. and Jankowski, P. and Dilić, M. and Lalić, N. and Lović, D. and Miličić, D. and Vulić, D. and Begić, A. and Durak Nalbantić, A. and Hadzibegić, N. and Kapidjić, S. and Resić, N. and Sabanović Bajramović, N. and Zvizdić, F. and Kovacević-Preradović, T. and Popović-Pejicić, S. and Đekić, D. and Gnjatić, T. and Knezević, T. and Stanetić, B. and Topić, G. and Milicić, D. and Bosnić, A. and Dubravcić, M. and Pavasović, S. and Samardžić, Jelena and Batinić, T. and Delić-Brkljacić, D. and Golubić, K. and Kordić, K. and Nedić, M. and Olujić, D. and Sedinić, V. and Blazević, T. and Pasalić, A. and Percić, M. and Sikić, J. and Aleksić, M. and Đokić, Jelena and Hinić, S. and Zdravković, M. and Lalić, N.M. and Jotić, A. and Lalić, K. and Lukić, L. and Milicić, T. and Macesić, M. and Stanarcić Gajović, J. and Stoiljković, M. and Đorđević, D. and Kostić, S. and Tasić, I. and Vuković, A. and Kugonjič, U. and (broj koatora 519)", year = "2019", abstract = "Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.", publisher = "Elsevier Ireland Ltd", journal = "Atherosclerosis", title = "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries", pages = "146-135", volume = "285", doi = "10.1016/j.atherosclerosis.2019.03.014" }
De Backer, G., Jankowski, P., Dilić, M., Lalić, N., Lović, D., Miličić, D., Vulić, D., Begić, A., Durak Nalbantić, A., Hadzibegić, N., Kapidjić, S., Resić, N., Sabanović Bajramović, N., Zvizdić, F., Kovacević-Preradović, T., Popović-Pejicić, S., Đekić, D., Gnjatić, T., Knezević, T., Stanetić, B., Topić, G., Milicić, D., Bosnić, A., Dubravcić, M., Pavasović, S., Samardžić, J., Batinić, T., Delić-Brkljacić, D., Golubić, K., Kordić, K., Nedić, M., Olujić, D., Sedinić, V., Blazević, T., Pasalić, A., Percić, M., Sikić, J., Aleksić, M., Đokić, J., Hinić, S., Zdravković, M., Lalić, N.M., Jotić, A., Lalić, K., Lukić, L., Milicić, T., Macesić, M., Stanarcić Gajović, J., Stoiljković, M., Đorđević, D., Kostić, S., Tasić, I., Vuković, A., Kugonjič, U.,& (broj koatora 519). (2019). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. in Atherosclerosis Elsevier Ireland Ltd., 285, 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014
De Backer G, Jankowski P, Dilić M, Lalić N, Lović D, Miličić D, Vulić D, Begić A, Durak Nalbantić A, Hadzibegić N, Kapidjić S, Resić N, Sabanović Bajramović N, Zvizdić F, Kovacević-Preradović T, Popović-Pejicić S, Đekić D, Gnjatić T, Knezević T, Stanetić B, Topić G, Milicić D, Bosnić A, Dubravcić M, Pavasović S, Samardžić J, Batinić T, Delić-Brkljacić D, Golubić K, Kordić K, Nedić M, Olujić D, Sedinić V, Blazević T, Pasalić A, Percić M, Sikić J, Aleksić M, Đokić J, Hinić S, Zdravković M, Lalić N, Jotić A, Lalić K, Lukić L, Milicić T, Macesić M, Stanarcić Gajović J, Stoiljković M, Đorđević D, Kostić S, Tasić I, Vuković A, Kugonjič U, (broj koatora 519). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. in Atherosclerosis. 2019;285:135-146. doi:10.1016/j.atherosclerosis.2019.03.014 .
De Backer, G., Jankowski, P., Dilić, M., Lalić, N., Lović, D., Miličić, D., Vulić, D., Begić, A., Durak Nalbantić, A., Hadzibegić, N., Kapidjić, S., Resić, N., Sabanović Bajramović, N., Zvizdić, F., Kovacević-Preradović, T., Popović-Pejicić, S., Đekić, D., Gnjatić, T., Knezević, T., Stanetić, B., Topić, G., Milicić, D., Bosnić, A., Dubravcić, M., Pavasović, S., Samardžić, Jelena, Batinić, T., Delić-Brkljacić, D., Golubić, K., Kordić, K., Nedić, M., Olujić, D., Sedinić, V., Blazević, T., Pasalić, A., Percić, M., Sikić, J., Aleksić, M., Đokić, Jelena, Hinić, S., Zdravković, M., Lalić, N.M., Jotić, A., Lalić, K., Lukić, L., Milicić, T., Macesić, M., Stanarcić Gajović, J., Stoiljković, M., Đorđević, D., Kostić, S., Tasić, I., Vuković, A., Kugonjič, U., (broj koatora 519), "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries" in Atherosclerosis, 285 (2019):135-146, https://doi.org/10.1016/j.atherosclerosis.2019.03.014 . .